These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 18817930)

  • 21. Methylphenidate improves cognitive deficits produced by infantile iron deficiency in rats.
    Mohamed WM; Unger EL; Kambhampati SK; Jones BC
    Behav Brain Res; 2011 Jan; 216(1):146-52. PubMed ID: 20655955
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The effects of methylphenidate on various components of visual attention in children with attention-deficit hyperactivity disorder].
    Durukan I; Türkbay T; Cöngöloğlu A
    Turk Psikiyatri Derg; 2008; 19(4):358-64. PubMed ID: 19110977
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cognitive effects of immediate-release methylphenidate in children with attention-deficit/hyperactivity disorder.
    Pietrzak RH; Mollica CM; Maruff P; Snyder PJ
    Neurosci Biobehav Rev; 2006; 30(8):1225-45. PubMed ID: 17161238
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of once-daily oral and transdermal methylphenidate on sleep behavior of children with ADHD.
    Faraone SV; Glatt SJ; Bukstein OG; Lopez FA; Arnold LE; Findling RL
    J Atten Disord; 2009 Jan; 12(4):308-15. PubMed ID: 18400982
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-term tolerability of the methylphenidate transdermal system in pediatric attention-deficit/hyperactivity disorder: a multicenter, prospective, 12-month, open-label, uncontrolled, phase III extension of four clinical trials.
    Findling RL; Wigal SB; Bukstein OG; Boellner SW; Abikoff HB; Turnbow JM; Civil R
    Clin Ther; 2009 Aug; 31(8):1844-55. PubMed ID: 19808143
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Does methylphenidate reduce the symptoms of chronic fatigue syndrome?
    Blockmans D; Persoons P; Van Houdenhove B; Bobbaers H
    Am J Med; 2006 Feb; 119(2):167.e23-30. PubMed ID: 16443425
    [TBL] [Abstract][Full Text] [Related]  

  • 27. No elevated genomic damage in children and adolescents with attention deficit/hyperactivity disorder after methylphenidate therapy.
    Walitza S; Kämpf K; Artamonov N; Romanos M; Gnana Oli R; Wirth S; Warnke A; Gerlach M; Stopper H
    Toxicol Lett; 2009 Jan; 184(1):38-43. PubMed ID: 19015014
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fatigue-related diurnal variations of cognitive performance in multiple sclerosis and stroke patients.
    Claros-Salinas D; Bratzke D; Greitemann G; Nickisch N; Ochs L; Schröter H
    J Neurol Sci; 2010 Aug; 295(1-2):75-81. PubMed ID: 20510427
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A randomized, double-blind and placebo-controlled trial of modafinil in children and adolescents with attention deficit and hyperactivity disorder.
    Kahbazi M; Ghoreishi A; Rahiminejad F; Mohammadi MR; Kamalipour A; Akhondzadeh S
    Psychiatry Res; 2009 Aug; 168(3):234-7. PubMed ID: 19439364
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Graphomotor functions in children with attention deficit hyperactivity disorder (ADHD)].
    Stasik D; Tucha O; Tucha L; Walitza S; Lange KW
    Psychiatr Pol; 2009; 43(2):183-92. PubMed ID: 19697788
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Attention-deficit hyperactivity disorder, methylphenidate, and primary encopresis.
    Golubchik P; Weizman A
    Psychosomatics; 2009; 50(2):178. PubMed ID: 19377031
    [No Abstract]   [Full Text] [Related]  

  • 32. Association between homozygosity of a G allele of the alpha-2a-adrenergic receptor gene and methylphenidate response in Korean children and adolescents with attention-deficit/hyperactivity disorder.
    Cheon KA; Cho DY; Koo MS; Song DH; Namkoong K
    Biol Psychiatry; 2009 Apr; 65(7):564-70. PubMed ID: 19150055
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Methylphenidate hydrochloride improves cognitive function in patients with advanced cancer and hypoactive delirium: a prospective clinical study.
    Gagnon B; Low G; Schreier G
    J Psychiatry Neurosci; 2005 Mar; 30(2):100-7. PubMed ID: 15798785
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effect of methylphenidate on Internet video game play in children with attention-deficit/hyperactivity disorder.
    Han DH; Lee YS; Na C; Ahn JY; Chung US; Daniels MA; Haws CA; Renshaw PF
    Compr Psychiatry; 2009; 50(3):251-6. PubMed ID: 19374970
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The effects of methylphenidate on cognitive-attentional processes. The use of continuous performance tests].
    Fernández-Jaén A; Martín Fernández-Mayoralas D; Calleja-Pérez B; Moreno-Acero N; Muñoz-Jareño N
    Rev Neurol; 2008; 46 Suppl 1():S47-9. PubMed ID: 18302122
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Methylphenidate improves working memory and set-shifting in AD/HD: relationships to baseline memory capacity.
    Mehta MA; Goodyer IM; Sahakian BJ
    J Child Psychol Psychiatry; 2004 Feb; 45(2):293-305. PubMed ID: 14982243
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cognitive dysfunction in multiple sclerosis: methods and prevalence from the GEDMA Study.
    Olazarán J; Cruz I; Benito-León J; Morales JM; Duque P; Rivera-Navarro J
    Eur Neurol; 2009; 61(2):87-93. PubMed ID: 19039226
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sustained-release methylphenidate for cognitive impairment in HIV-1-infected drug abusers: a pilot study.
    van Dyck CH; McMahon TJ; Rosen MI; O'Malley SS; O'Connor PG; Lin CH; Pearsall HR; Woods SW; Kosten TR
    J Neuropsychiatry Clin Neurosci; 1997; 9(1):29-36. PubMed ID: 9017526
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Controlled clinical trial of zolpidem for the treatment of insomnia associated with attention-deficit/ hyperactivity disorder in children 6 to 17 years of age.
    Blumer JL; Findling RL; Shih WJ; Soubrane C; Reed MD
    Pediatrics; 2009 May; 123(5):e770-6. PubMed ID: 19403468
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Methylphenidate improves fatigue scores in Parkinson disease: a randomized controlled trial.
    Mendonça DA; Menezes K; Jog MS
    Mov Disord; 2007 Oct; 22(14):2070-6. PubMed ID: 17674415
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.